David Carlson
About David Carlson
David Carlson is an Associate Equities Analyst specializing in healthcare at Wedbush Securities, where he has worked since 2021. He has a background in scientific research and financial analysis, having previously held positions at i2 Pharmaceuticals and UC Davis.
Work at Wedbush Securities
David Carlson serves as an Associate Equities Analyst in the Healthcare sector at Wedbush Securities. He has held this position since 2021, contributing to the analysis of healthcare equities. His role involves leveraging his scientific background to inform financial assessments and investment strategies within the healthcare industry. Carlson's experience in both scientific research and financial analysis enhances his ability to evaluate healthcare companies effectively.
Education and Expertise
David Carlson holds a Master's degree in Financial Analysis from the University of San Francisco, where he studied from 2019 to 2020. Prior to this, he completed his Ph.D. in Biochemistry & Molecular Biology at UC Davis, where he was a graduate student from 2006 to 2012. His educational background combines rigorous scientific training with financial analysis, equipping him with a unique interdisciplinary perspective that he applies in his current role.
Background in Pharmaceuticals
Before transitioning to financial analysis, David Carlson worked in the pharmaceutical sector. He was a Scientist II at i2 Pharmaceuticals from 2018 to 2019, where he contributed to research and development efforts. Additionally, he worked at UC Davis in the Abel Lab from 2005 to 2006. This background in scientific research provides him with valuable insights into the healthcare industry, which he utilizes in his current analytical role.
Experience in Academic Research
David Carlson has extensive experience in academic research, having spent six years as a graduate student at UC Davis. During this time, he focused on Biochemistry & Molecular Biology, which laid the foundation for his scientific expertise. His academic journey included various research projects that contributed to his understanding of complex biological systems, further informing his analytical capabilities in finance.